Search Results

Site Search

Dementia - Insights

Mayo Clinic Laboratories’ comprehensive dementia testing menu includes evaluations for Alzheimer's disease, autoimmune dementia, and rapidly progressive dementia.

B-cell lymphoma - Insights

Check out how Mayo Clinic Laboratories’ full menu of B-cell lymphoma testing, which includes next-generation sequencing and FISH testing, can inform diagnosis and prognosis for patients.

High-Sensitivity Troponin Assay Promises Novel Uses in Managing Patients with Chronic Heart Disease - Insights

After a long wait, the U.S. Food and Drug Administration has finally approved the Elecsys Troponin T Gen 5 STAT blood test. Recently, the Beckman hscTnI assay was also approved. These high-sensitivity troponin assays will benefit emergency...

Advancing Multiple Myeloma Diagnosis - Insights

The standard laboratory test to diagnose multiple myeloma dates back to the Eisenhower administration. Research at Mayo Clinic spearheaded by David Murray, M.D., Ph.D. (PATH ’10), and fueled by his experience as an industrial chemist has...

How an ex-NFL Linebacker Overcame His Greatest Opponent, Amyloidosis - Insights

Matt Millen, ex-pro NFL player, who played on four Super Bowl-winning teams underwent a nearly six-year medical journey in search for answers. Finally, he was diagnosed with amyloidosis using a new testing methodology at Mayo Clinic.

Beyond the Test Result: Greg Widseth - Insights

Greg Widseth was suddenly hit by a rare disease that prompted his immune system to attack his brain cells, resulting in as many as 60 seizures a day. Special blood and spinal fluid tests developed by Mayo Medical Laboratories confirmed that...

Our staff, our stories: Andrew "Roo" Yori - Insights

Andrew “Roo” Yori’s persistence and athletic gifts allowed him to achieve his dream of becoming an American Ninja Warrior in 2016.

Amid COVID-19 upheaval, DLMP staff steps up - Insights

When COVID-19 hit, staff in Laboratory Medicine and Pathology at Mayo Clinic rose to the challenge with perseverance, flexibility, and resilience.

Reclaiming strength and independence after rare cancer diagnosis: Alexa Lofaro - Insights

It’s been more than three years since a team of specialists and genetic testing by Mayo Clinic Laboratories helped pinpoint the cause of Alexa Lofaro’s failing health. And today, she says she continues to feel “so much better” than she did...

Neurofilament light chain test helps in diagnosis, treatment, and prognosis of ALS and MS - Insights

By using a test that measures neurofilament light chain (Nfl) proteins in blood, clinicians can better diagnose devastating diseases like ALS and MS, help predict disease progression, and better assess efficacy of existing drugs and trial...